Katiyar will focus on fueling product and technology development for SilcsBio

August 24, 2021, Baltimore, MD – – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of Ankita Katiyar, PhD as Applications Scientist focusing on product development.

Katiyar – a chemist with expertise in a range of areas including molecular dynamics and quantum mechanics – recently completed her PhD in Chemistry from the University of Kansas. She earned a BS-MS dual degree in Chemistry (major) and Mathematics (minor) at the Indian Institute of Science Education & Research Bhopal in Bhopal, India.

Katiyar’s extensive research and lab experience includes numerous publications in peer-reviewed journals and conference presentations on a range of topics including supramolecular chemistry and peptide dynamics.

In addition, Katiyar also was an Intern at the Shell Technology Center Bangalore in Karnataka, India, where she worked with the experimental and computational R&D teams at Shell Technology Center Houston.

“Ankita expands our expertise in our growing team of computational scientists with SilcsBio,” said Ken Malone, CEO of SilcsBio.

About SilcsBio:
SilcsBio, LLC offers a platform technology that advances computational drug design applications through detailed protein mapping that accounts for flexibility and solvation and enables highly efficient ligand binding evaluation, virtual screening, and more. SilcsBio software and services span from target protein mapping and analysis through lead optimization and offers key
insights for biological therapeutic formulations. The proprietary software unlocks hidden binding hotspots of target proteins and reveals the preferred ligand chemistries at those sites to rapidly guide the drug design process. SilcsBio most recently announced a partnership with Aikido Pharmaceuticals. Learn more: www.silcsbio.com

Media Contact:
Tina Guvench
(410) 401-9794, ext. 701